Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
Zai Lab Statement on Executive Management Team’s Agreement on Share Activities
Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
Zai Lab to Present Data Highlighting ZL-1310
Zai Lab Announces Participation in March Investor Conference
Zai Lab to Present Final OS Data from Phase 3 NORA Study of ZEJULA
Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates
Zai Lab to Announce Full-Year 2023 Financial Results